Yuko Iwata

5.8k total citations
208 papers, 4.5k citations indexed

About

Yuko Iwata is a scholar working on Toxicology, Molecular Biology and Spectroscopy. According to data from OpenAlex, Yuko Iwata has authored 208 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Toxicology, 63 papers in Molecular Biology and 57 papers in Spectroscopy. Recurrent topics in Yuko Iwata's work include Forensic Toxicology and Drug Analysis (94 papers), Analytical Chemistry and Chromatography (47 papers) and Psychedelics and Drug Studies (31 papers). Yuko Iwata is often cited by papers focused on Forensic Toxicology and Drug Analysis (94 papers), Analytical Chemistry and Chromatography (47 papers) and Psychedelics and Drug Studies (31 papers). Yuko Iwata collaborates with scholars based in Japan, United States and Belgium. Yuko Iwata's co-authors include Tatsuyuki Kanamori, Kenji Tsujikawa, Kenji Kuwayama, Munekazu Shigekawa, Hajime Miyaguchi, Shigeo Wakabayashi, Hiroyuki Inoue, Yuki Katanosaka, Tadashi Yamamuro and Yuji Arai and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Yuko Iwata

197 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Iwata Japan 34 1.7k 1.2k 785 766 696 208 4.5k
Nerea Ferreirós Germany 39 1.8k 1.1× 423 0.4× 339 0.4× 118 0.2× 341 0.5× 137 4.3k
Pier Giovanni Baraldi Italy 58 4.9k 2.8× 328 0.3× 116 0.1× 469 0.6× 1.0k 1.4× 319 11.1k
Jürg Gertsch Switzerland 47 2.4k 1.4× 377 0.3× 160 0.2× 147 0.2× 1.1k 1.6× 205 7.7k
Xiang‐Qun Xie United States 35 2.5k 1.4× 170 0.1× 180 0.2× 99 0.1× 913 1.3× 165 5.3k
Meng Cui United States 28 2.8k 1.6× 78 0.1× 169 0.2× 591 0.8× 656 0.9× 102 5.2k
Thomas Stockner Austria 34 1.5k 0.9× 261 0.2× 143 0.2× 205 0.3× 947 1.4× 106 2.8k
Kenneth J. Broadley United Kingdom 29 1.3k 0.7× 433 0.4× 49 0.1× 69 0.1× 730 1.0× 215 3.6k
Helena Carmo Portugal 34 884 0.5× 1.1k 0.9× 151 0.2× 17 0.0× 769 1.1× 113 3.6k
Yukihiro Shoyama Japan 53 5.8k 3.3× 321 0.3× 203 0.3× 46 0.1× 684 1.0× 371 10.7k
Sumner Burstein United States 44 1.1k 0.6× 606 0.5× 92 0.1× 61 0.1× 1.5k 2.1× 131 5.5k

Countries citing papers authored by Yuko Iwata

Since Specialization
Citations

This map shows the geographic impact of Yuko Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Iwata more than expected).

Fields of papers citing papers by Yuko Iwata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Iwata. The network helps show where Yuko Iwata may publish in the future.

Co-authorship network of co-authors of Yuko Iwata

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Iwata. A scholar is included among the top collaborators of Yuko Iwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Iwata. Yuko Iwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumura, Tsuyoshi, Takayasu Fukudome, Yasufumi Motoyoshi, et al.. (2025). Efficacy of tranilast in preventing exacerbating cardiac function and death from heart failure in muscular dystrophy patients with advanced-stage heart failure: a single-arm, open-label, multicenter study. Orphanet Journal of Rare Diseases. 20(1). 13–13. 1 indexed citations
2.
Tsujikawa, Kenji, Yuki Okada, Hiroki Segawa, et al.. (2025). Development of a novel Δ9-THC-specific color test reagent. Forensic Toxicology. 43(2). 318–332.
3.
Segawa, Hiroki, Yuko Iwata, Yuki Okada, et al.. (2024). Low-frequency Raman spectrum of methamphetamine hydrochloride and its alterations induced by impurities. Forensic Chemistry. 40. 100601–100601.
4.
Kuwayama, Kenji, Hajime Miyaguchi, Tatsuyuki Kanamori, et al.. (2024). Development of a method to evaluate the effects of external environments on drug stability in nails using micro‐segmental analysis. Drug Testing and Analysis. 17(2). 188–197. 1 indexed citations
5.
Segawa, Hiroki, Tadashi Yamamuro, Kenji Kuwayama, et al.. (2024). Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐d‐lysergic acid diethylamide (1T‐AL‐LAD). Drug Testing and Analysis. 17(4). 494–501. 5 indexed citations
6.
Kanamori, Tatsuyuki, Hiroki Segawa, Tadashi Yamamuro, et al.. (2024). Metabolism of highly potent synthetic opioid nitazene analogs: N‐ethyl‐N‐(1‐glucuronyloxyethyl) metabolite formation and degradation to N‐desethyl metabolites during enzymatic hydrolysis. Drug Testing and Analysis. 17(2). 238–249. 9 indexed citations
8.
Kuwayama, Kenji, Hajime Miyaguchi, Tatsuyuki Kanamori, et al.. (2022). Micro-segmental hair analysis: detailed procedures and applications in forensic toxicology. Forensic Toxicology. 40(2). 215–233. 20 indexed citations
9.
Kuwayama, Kenji, Hajime Miyaguchi, Tatsuyuki Kanamori, et al.. (2021). Development of an improved method to estimate the days of continuous drug ingestion, based on the micro‐segmental hair analysis. Drug Testing and Analysis. 13(7). 1295–1304. 9 indexed citations
11.
Kuwayama, Kenji, Hajime Miyaguchi, Yuko Iwata, et al.. (2018). Estimation of day of death using micro-segmental hair analysis based on drug use history: a case of lidocaine use as a marker. International Journal of Legal Medicine. 133(1). 117–122. 13 indexed citations
12.
Iwata, Yuko, Tatsuyuki Kanamori, Kenji Tsujikawa, et al.. (2015). Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography–chemical ionization-tandem mass spectrometry. Forensic Toxicology. 33(2). 338–347. 18 indexed citations
13.
Kanda, Koji, Kenji Tsujikawa, Kenji Kuwayama, et al.. (2014). Differentiation of regioisomeric methylamphetamines by GC/MS. 19(2). 111–119. 4 indexed citations
14.
Kuwayama, Kenji, Kenji Tsujikawa, Tatsuyuki Kanamori, Yuko Iwata, & Hiroyuki Inoue. (2013). Rapid Morphological Examination of Cannabis and Its Related Herbal Products. 18(2). 135–141. 1 indexed citations
15.
Inoue, Hiroyuki, Yuko Iwata, Tatsuyuki Kanamori, et al.. (2004). Analysis of Benzylpiperazine-like Compounds. 9(2). 165–184. 10 indexed citations
16.
Kanamori, Tatsuyuki, Kenji Tsujikawa, Yuko Iwata, et al.. (2003). Excretory Profile of 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) in Rat.. JOURNAL OF HEALTH SCIENCE. 49(2). 166–169. 23 indexed citations
17.
Iwata, Yuko, et al.. (1996). Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 40(8). 1835–1842. 73 indexed citations
18.
Iwata, Yuko, Hironori Hanada, Masami Takahashi, & Munekazu Shigekawa. (1994). Ca2+‐ATPase distributes differently in cardiac sarcolemma than dihydropyridine receptor α1 subunit and Na+/Ca2+ exchanger. FEBS Letters. 355(1). 65–68. 12 indexed citations
19.
Fugo, Hajime & Yuko Iwata. (1983). The presence of the eclosion hormone activity in the crude brain hormone and Bombyx eclosion hormone assay. Nihon sanshigaku zasshi. 52(1). 71–78. 10 indexed citations
20.
Fugo, Hajime & Yuko Iwata. (1983). Change of eclosion hormone activity in the brain during the pupal-adult development in the silkworm, Bombyx mori. Nihon sanshigaku zasshi. 52(1). 79–84. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026